Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

Similar articles for PubMed (Select 24128000)

1.

Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates.

Rami M, Dubois L, Parvathaneni NK, Alterio V, van Kuijk SJ, Monti SM, Lambin P, De Simone G, Supuran CT, Winum JY.

J Med Chem. 2013 Nov 14;56(21):8512-20. doi: 10.1021/jm4009532. Epub 2013 Oct 31.

PMID:
24128000
2.

QSAR studies of sulfamate and sulfamide inhibitors targeting human carbonic anhydrase isozymes I, II, IX and XII.

Tarko L, Supuran CT.

Bioorg Med Chem. 2013 Mar 15;21(6):1404-9. doi: 10.1016/j.bmc.2012.11.004. Epub 2012 Nov 10.

PMID:
23206986
3.
4.

Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides.

Pastorekova S, Vullo D, Casini A, Scozzafava A, Pastorek J, Nishimori I, Supuran CT.

J Enzyme Inhib Med Chem. 2005 Jun;20(3):211-7.

PMID:
16119190
5.

Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates.

Winum JY, Vullo D, Casini A, Montero JL, Scozzafava A, Supuran CT.

J Med Chem. 2003 Dec 4;46(25):5471-7.

PMID:
14640555
6.

Carbonic anhydrase inhibitors; fluorinated phenyl sulfamates show strong inhibitory activity and selectivity for the inhibition of the tumor-associated isozymes IX and XII over the cytosolic ones I and II.

Winum JY, Innocenti A, Vullo D, Montero JL, Supuran CT.

Bioorg Med Chem Lett. 2009 Sep 1;19(17):5082-5. doi: 10.1016/j.bmcl.2009.07.056. Epub 2009 Jul 23.

PMID:
19632111
7.

Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.

Almajan GL, Innocenti A, Puccetti L, Manole G, Barbuceanu S, Saramet I, Scozzafava A, Supuran CT.

Bioorg Med Chem Lett. 2005 May 2;15(9):2347-52.

PMID:
15837323
8.
9.

Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII.

Rami M, Maresca A, Smaine FZ, Montero JL, Scozzafava A, Winum JY, Supuran CT.

Bioorg Med Chem Lett. 2011 May 15;21(10):2975-9. doi: 10.1016/j.bmcl.2011.03.055. Epub 2011 Mar 21.

PMID:
21470859
12.

Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-binding, more isoform-selective inhibitors.

Vitale RM, Alterio V, Innocenti A, Winum JY, Monti SM, De Simone G, Supuran CT.

J Med Chem. 2009 Oct 8;52(19):5990-8. doi: 10.1021/jm900641r.

PMID:
19731956
13.

Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides.

Akdemir A, G├╝zel-Akdemir O, Scozzafava A, Capasso C, Supuran CT.

Bioorg Med Chem. 2013 Sep 1;21(17):5228-32. doi: 10.1016/j.bmc.2013.06.029. Epub 2013 Jun 20.

PMID:
23842519
14.

Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.

Puccetti L, Fasolis G, Cecchi A, Winum JY, Gamberi A, Montero JL, Scozzafava A, Supuran CT.

Bioorg Med Chem Lett. 2005 May 2;15(9):2359-64.

PMID:
15837325
15.

Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.

Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.

Bioorg Med Chem Lett. 2004 Nov 1;14(21):5427-33.

PMID:
15454239
16.

5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.

Leitans J, Sprudza A, Tanc M, Vozny I, Zalubovskis R, Tars K, Supuran CT.

Bioorg Med Chem. 2013 Sep 1;21(17):5130-8. doi: 10.1016/j.bmc.2013.06.041. Epub 2013 Jun 27.

PMID:
23859774
17.

Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.

Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.

Bioorg Med Chem Lett. 2005 Jun 15;15(12):3102-8.

PMID:
15905091
18.

Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors.

Rosatelli E, Carotti A, Ceruso M, Supuran CT, Gioiello A.

Bioorg Med Chem Lett. 2014 Aug 1;24(15):3422-5. doi: 10.1016/j.bmcl.2014.05.086. Epub 2014 Jun 4.

PMID:
24948563
19.

Cyclic tertiary sulfamates: selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives.

De Monte C, Carradori S, Secci D, D'Ascenzio M, Vullo D, Ceruso M, Supuran CT.

Eur J Med Chem. 2014 Sep 12;84:240-6. doi: 10.1016/j.ejmech.2014.07.014. Epub 2014 Jul 8.

PMID:
25019479
20.

Glycosidic carbonic anhydrase IX inhibitors: a sweet approach against cancer.

Winum JY, Colinas PA, Supuran CT.

Bioorg Med Chem. 2013 Mar 15;21(6):1419-26. doi: 10.1016/j.bmc.2012.10.043. Epub 2012 Nov 10. Review.

PMID:
23199483
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk